Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Total 13F shares
-
25,625,855
-
Share change
-
+2,980,681
-
Total reported value
-
$293,412,781
-
Put/Call ratio
-
51%
-
Price per share
-
$11.45
-
Number of holders
-
104
-
Value change
-
+$48,054,170
-
Number of buys
-
75
-
Number of sells
-
36
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2023
As of 30 Jun 2023,
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,625,855 shares.
The largest 10 holders included
EcoR1 Capital, LLC, ARMISTICE CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Erste Asset Management GmbH, D. E. Shaw & Co., Inc., MORGAN STANLEY, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
105
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.